{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:03:44Z","timestamp":1793253824426,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Airway eosinophilia is typical of asthma, and many controller treatments target eosinophilic disease. Asthma is clinically heterogeneous, however, and a subgroup of people with asthma do not have airway eosinophilia. The size of this subgroup is uncertain because prior studies have not examined repeated measures of sputum cytology to determine when people with asthma have intermittent versus persistent sputum eosinophila and when they are persistently noneosinophilic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the prevalence and clinical characteristics of the noneosinophilic asthma phenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed sputum cytology data from 995 subjects with asthma enrolled in clinical trials in the Asthma Clinical Research Network where they had undergone sputum induction and measures of sputum cytology, often repeatedly, and assessment of responses to standardized asthma treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>In cross-sectional analyses, sputum eosinophilia (\u22652% eosinophils) was found in only 36% of subjects with asthma not taking an inhaled corticosteroid (ICS) and 17% of ICS-treated subjects with asthma; an absence of eosinophilia was noted frequently, even in subjects with asthma whose disease was suboptimally controlled. In repeated measures analyses of people with asthma not taking an ICS, 22% of subjects had sputum eosinophilia on every occasion (persistent eosinophilia); 31% had eosinophilia on at least one occasion (intermittent eosinophilia); and 47% had no eosinophilia on every occasion (persistently noneosinophilic). Two weeks of combined antiinflammatory therapy caused significant improvements in airflow obstruction in eosinophilic asthma, but not in persistently noneosinophilic asthma. In contrast, bronchodilator responses to albuterol were similar in eosinophilic and noneosinophilic asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Approximately half of patients with mild-to-moderate asthma have persistently noneosinophilic disease, a disease phenotype that responds poorly to currently available antiinflammatory therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201109-1640oc","type":"journal-article","created":{"date-parts":[[2012,1,21]],"date-time":"2012-01-21T00:48:39Z","timestamp":1327106919000},"page":"612-619","source":"Crossref","is-referenced-by-count":432,"title":["A Large Subgroup of Mild-to-Moderate Asthma Is Persistently Noneosinophilic"],"prefix":"10.1093","volume":"185","author":[{"given":"Kelly Wong","family":"McGrath","sequence":"first","affiliation":[{"name":"Cardiovascular Research Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolina","family":"Icitovic","sequence":"additional","affiliation":[{"name":"Public Health Sciences, Penn State Hershey College of Medicine, Hershey, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homer A.","family":"Boushey","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Lazarus","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Rand","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Jewish Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon M.","family":"Chinchilli","sequence":"additional","affiliation":[{"name":"Public Health Sciences, Penn State Hershey College of Medicine, Hershey, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Fahy","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,15]]},"reference":[{"key":"2026032101155100400_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2010.10.020","article-title":"Costs of asthma in the United States: 2002\u20132007","volume":"127","author":"Barnett","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101155100400_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaci.2009.06.029","article-title":"Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study","volume":"124","author":"van Veen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101155100400_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/thx.2009.126722","article-title":"Effects of steroid therapy on inflammatory cell subtypes in asthma","volume":"65","author":"Cowan","year":"2010","journal-title":"Thorax"},{"key":"2026032101155100400_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1752-699X.2009.00162.x","article-title":"Inflammatory phenotypes in adult asthma: clinical applications","volume":"3","author":"Gibson","year":"2009","journal-title":"Clin Respir J"},{"key":"2026032101155100400_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaci.2011.03.035","article-title":"Therapeutic strategies to reduce asthma exacerbations","volume":"128","author":"O'Byrne","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101155100400_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1165\/rcmb.2011-0013TR","article-title":"Targeting eosinophil's biology in asthma therapy","volume":"45","author":"Wegmann","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026032101155100400_bib7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaci.2004.12.1129","article-title":"Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids","volume":"115","author":"Deykin","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101155100400_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaci.2006.10.035","article-title":"The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial","volume":"119","author":"Martin","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101155100400_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mai.2002.122635","article-title":"Significant variability in response to inhaled corticosteroids for persistent asthma","volume":"109","author":"Szefler","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101155100400_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/thx.2006.073429","article-title":"Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma","volume":"62","author":"Berry","year":"2007","journal-title":"Thorax"},{"key":"2026032101155100400_bib12","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1378\/chest.07-1047","article-title":"Association between neutrophilic airway inflammation and airflow limitation in adults with asthma","volume":"132","author":"Shaw","year":"2007","journal-title":"Chest"},{"key":"2026032101155100400_bib13","first-page":"144","article-title":"Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice","volume":"18","author":"D'Silva","year":"2011","journal-title":"Can Respir J"},{"key":"2026032101155100400_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet"},{"key":"2026032101155100400_bib15","doi-asserted-by":"crossref","first-page":"207S","DOI":"10.1016\/S0197-2456(01)00164-7","article-title":"Quality control within the Asthma Clinical Research Network","volume":"22","author":"Martin","year":"2001","journal-title":"Control Clin Trials"},{"key":"2026032101155100400_bib16","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1001\/jama.285.20.2594","article-title":"Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial","volume":"285","author":"Lemanske","year":"2001","journal-title":"JAMA"},{"key":"2026032101155100400_bib17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa042552","article-title":"Daily versus as-needed corticosteroids for mild persistent asthma","volume":"352","author":"Boushey","year":"2005","journal-title":"N Engl J Med"},{"key":"2026032101155100400_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1164\/rccm.200601-112OC","article-title":"Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma","volume":"175","author":"Deykin","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.200511-1746OC","article-title":"Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma","volume":"175","author":"Lazarus","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib20","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N Engl J Med"},{"key":"2026032101155100400_bib21","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2010.07.024","article-title":"A trial of clarithromycin for the treatment of suboptimally controlled asthma","volume":"126","author":"Sutherland","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101155100400_bib22"},{"key":"2026032101155100400_bib23","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1183\/09031936.96.09122448","article-title":"Comparison of two methods of collecting induced sputum in asthmatic subjects","volume":"9","author":"Gershman","year":"1996","journal-title":"Eur Respir J"},{"key":"2026032101155100400_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/ajrccm.156.1.9610114","article-title":"Safety of one method of sputum induction in asthmatic subjects","volume":"156","author":"Wong","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/ajrccm.161.2.9903097","article-title":"Induced sputum cell counts in healthy adults","volume":"161","author":"Belda","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1164\/ajrccm.162.3.9908057","article-title":"Induced sputum cellularity. Reference values and distribution in normal volunteers","volume":"162","author":"Spanevello","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/thorax.57.10.875","article-title":"Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids","volume":"57","author":"Green","year":"2002","journal-title":"Thorax"},{"key":"2026032101155100400_bib28","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.119.5.1329","article-title":"Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8","volume":"119","author":"Gibson","year":"2001","journal-title":"Chest"},{"key":"2026032101155100400_bib29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0091-6749(95)70128-1","article-title":"Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation","volume":"95","author":"Fahy","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101155100400_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999\u20132008","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"key":"2026032101155100400_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1164\/ajrccm.160.2.9809038","article-title":"Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk","volume":"160","author":"Halonen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/09031936.06.00077205","article-title":"Influence of body mass index on the response to asthma controller agents","volume":"27","author":"Peters-Golden","year":"2006","journal-title":"Eur Respir J"},{"key":"2026032101155100400_bib35","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jaci.2009.04.005","article-title":"Body mass index and phenotype in subjects with mild-to-moderate persistent asthma","volume":"123","author":"Sutherland","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101155100400_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1164\/rccm.200802-301OC","article-title":"The association between obesity and asthma: interactions between systemic and airway inflammation","volume":"178","author":"Sutherland","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.1201475","article-title":"Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis","volume":"332","author":"Wu","year":"2011","journal-title":"Science"},{"key":"2026032101155100400_bib38","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"2026032101155100400_bib39","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(99)01813-9","article-title":"Non-eosinophilic corticosteroid unresponsive asthma","volume":"353","author":"Pavord","year":"1999","journal-title":"Lancet"},{"key":"2026032101155100400_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-130-6-199903160-00005","article-title":"Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Montelukast\/Beclomethasone Study Group","volume":"130","author":"Malmstrom","year":"1999","journal-title":"Ann Intern Med"},{"key":"2026032101155100400_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1164\/ajrccm.164.3.2008042","article-title":"Clinical importance of Alternaria exposure in children","volume":"164","author":"Downs","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101155100400_bib43","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1183\/09031936.06.00074705","article-title":"The link between fungi and severe asthma: a summary of the evidence","volume":"27","author":"Denning","year":"2006","journal-title":"Eur Respir J"},{"key":"2026032101155100400_bib44","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1164\/rccm.201001-0087OC","article-title":"IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma","volume":"182","author":"Fairs","year":"2010","journal-title":"Am J Respir Crit Care Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/6\/612\/67292869\/ajrccm_185_6_612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/6\/612\/67292869\/ajrccm_185_6_612.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:16:00Z","timestamp":1774070160000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/185\/6\/612\/8508229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,3,15]]},"published-print":{"date-parts":[[2012,3,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201109-1640oc","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14267232.790202803","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.14267232.15779412","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.14267232.15779538","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.14267232.790402839","asserted-by":"object"}]},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,3]]},"published":{"date-parts":[[2012,3]]}}}